Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

NCT04291885 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Merkel Cell Carcinoma
Merkel Cell Carcinoma, Stage I
Merkel Cell Carcinoma, Stage II
Merkel Cell Carcinoma, Stage III
Neuroendocrine Tumors
Carcinoma Neuroendocrine Skin

Interventions

DRUG: Avelumab
DRUG: Placebo

Sponsor

Melanoma and Skin Cancer Trials Limited